These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8140017)

  • 1. Warfarin treatment and migraine.
    Suresh CG; Neal D; Coupe MO
    Postgrad Med J; 1994 Jan; 70(819):37-8. PubMed ID: 8140017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of migraine attacks during the use of warfarin.
    Fragoso YD
    Headache; 1997; 37(10):667-8. PubMed ID: 9439091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of anticoagulant therapy in deep venous thrombosis in the lower limb in elderly, mobilized patients. A double-blind placebo controlled study with open therapeutic guidance].
    Ott P; Eldrup E; Oxholm P
    Ugeskr Laeger; 1988 Jan; 150(4):218-21. PubMed ID: 3287734
    [No Abstract]   [Full Text] [Related]  

  • 4. Audit of anticoagulant therapy of pulmonary embolus, deep vein thrombosis and thrombophlebitis.
    Meinhold JM; Reale EO; Miller WA
    Am J Hosp Pharm; 1979 Feb; 36(2):214-8. PubMed ID: 420210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Migraine and warfarin sodium].
    Lakartidningen; 1981 May; 78(21):2147. PubMed ID: 7266152
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Decreased sensitivity to oral anticoagulant therapy after attacks of migraine.
    Narasimhan P
    Lancet; 1974 Nov; 2(7889):1143. PubMed ID: 4139440
    [No Abstract]   [Full Text] [Related]  

  • 7. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
    Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant therapy for deep vein thrombosis: its proper application.
    Rohrer MJ; Anderson FA
    Semin Vasc Surg; 1996 Mar; 9(1):13-20. PubMed ID: 8665021
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of cinnarizine in the prophylaxis of migraine in children: a double-blind placebo-controlled randomized trial.
    Ashrafi MR; Salehi S; Malamiri RA; Heidari M; Hosseini SA; Samiei M; Tavasoli AR; Togha M
    Pediatr Neurol; 2014 Oct; 51(4):503-8. PubMed ID: 25023977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial.
    Fiesseler FW; Shih R; Szucs P; Silverman ME; Eskin B; Clement M; Saxena R; Allegra J; Riggs RL; Majlesi N
    J Emerg Med; 2011 Apr; 40(4):463-8. PubMed ID: 19846269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine responsive to warfarin: an update on anticoagulant possible role in migraine prophylaxis.
    Maggioni F; Bruno M; Mainardi F; Lisotto C; Zanchin G
    Neurol Sci; 2012 Dec; 33(6):1447-9. PubMed ID: 22222938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
    Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
    Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts of anticoagulation therapy.
    Hull RD; Pineo GF
    Clin Chest Med; 1995 Jun; 16(2):269-80. PubMed ID: 7656539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.